Cell line · CVCL_0220
COLO 320HSR
Cancer cell line, Homo sapiens. Colon adenocarcinoma. 17 papers.
4 sourcescell-lines-2026-11-14-0.1.0
Cite this record
ConductScience Library. COLO 320HSR. Cell lines, record CVCL_0220. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_0220
On this page
Cell line
As Cellosaurus gives it.
- Name
- COLO 320HSR
- Accession
- CVCL_0220
- RRID
- RRID:CVCL_0220
- Synonyms
- COLO-320HSR, COLO #320HSR COLO320HSR, COLO 320 HSR, COLO-320-HSR, COLO 320 (HSR), COLO-HSR, Colorado 320 Homogeneously Staining Regions
- Species
- Homo sapiens (Human)
- Sex
- Female
- Age at sampling
- 55Y
- Category
- Cancer cell line
- Diseases
- Colon adenocarcinoma (NCIt C4349)
- Derived from
- Colon, sigmoid (in situ)
- Parent
- COLO 320DM (CVCL_0219)
- Entry created
- 2012-04-04
- Entry updated
- 2026-06-25
Source Cellosaurus
Problems0
Cellosaurus records no problem for this cell line.
None in this release.
Papers17
1 more article gives this line's RRID in its Methods without naming the line nearby, so it is not listed.
| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| Selective Depletion of Cancer Cells with Extrachromosomal DNA via Lentiviral Infection. | Cancer Res Commun | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Extrachromosomal DNA-Driven Oncogene Dosage Heterogeneity Promotes Rapid Adaptation to Therapy in MYCN-Amplified Cancers. | Cancer Discov | 2025 | Its Methods give the RRID and name the line | PubMed | |
| Exploiting a subtype-specific mitochondrial vulnerability for successful treatment of colorectal peritoneal metastases. | Cell Rep Med | 2024 | Its Methods give the RRID and name the line | PubMed | |
| Spatial Profiling of Circular RNAs in Cancer Reveals High Expression in Muscle and Stromal Cells. | Cancer Res | 2023 | Its Methods give the RRID and name the line | PubMed | |
| Pan-cancer proteomic map of 949 human cell lines. | Cancer Cell | 2022 | Cellosaurus cites it | PubMed | |
| Aberrant Expression and Subcellular Localization of ECT2 Drives Colorectal Cancer Progression and Growth. | Cancer Res | 2022 | Its Methods give the RRID and name the line | PubMed | |
| Prioritization of cancer therapeutic targets using CRISPR-Cas9 screens. | Nature | 2019 | Cellosaurus cites it | PubMed | |
| An Interactive Resource to Probe Genetic Diversity and Estimated Ancestry in Cancer Cell Lines. | Cancer Res | 2019 | Cellosaurus cites it | PubMed | |
| Differential Effector Engagement by Oncogenic KRAS. | Cell Rep | 2018 | Cellosaurus cites it | PubMed | |
| Genomic Determinants of Protein Abundance Variation in Colorectal Cancer Cells. | Cell Rep | 2017 | Cellosaurus cites it | PubMed |
1 to 10 of 17
See all 17 papersRelatives1
| Relation | Cell line | Accession | Problem |
|---|---|---|---|
| Parent | COLO 320DM | CVCL_0219 |
Source Cell lines
Cell banks6
Data dates
The date of each source this release read.
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this cell line from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_0220
GET https://conductscience.org/api/cell-lines/v1/CVCL_0220/problems